Avidity Biosciences Inc. (RNA)
NASDAQ: RNA
· Real-Time Price · USD
30.94
0.59 (1.94%)
At close: May 28, 2025, 3:59 PM
30.90
-0.13%
After-hours: May 28, 2025, 07:22 PM EDT
1.94% (1D)
| Bid | 28.36 |
| Market Cap | 3.73B |
| Revenue (ttm) | 8.93M |
| Net Income (ttm) | -369.22M |
| EPS (ttm) | -3 |
| PE Ratio (ttm) | -10.31 |
| Forward PE | -6.92 |
| Analyst | Buy |
| Ask | 33 |
| Volume | 708,433 |
| Avg. Volume (20D) | 1,512,378 |
| Open | 30.50 |
| Previous Close | 30.35 |
| Day's Range | 30.00 - 31.36 |
| 52-Week Range | 21.51 - 56.00 |
| Beta | 0.99 |
Analyst Forecast
According to 0 analyst ratings, the average rating for RNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-18.65%
Shares of vaccine and gene therapy stocks are trad...
Unlock content with
Pro Subscription
2 months ago
+10.24%
Avidity Biosciences shares are trading higher after BMO Capital initiated coverage on the stock with an Outperform rating and anounced a $72 price target.
